home All News open_in_new Full Article
Johnson & Johnson presenta en España la combinación 'Rybrevant' y 'Lazcluze' para cáncer de pulmón no microcítico
today 34 h. ago attach_file Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Events
ID: 3949096504